HK1186378A1 - A composition and use thereof in the treatment of anal rhagades - Google Patents

A composition and use thereof in the treatment of anal rhagades

Info

Publication number
HK1186378A1
HK1186378A1 HK13113705.4A HK13113705A HK1186378A1 HK 1186378 A1 HK1186378 A1 HK 1186378A1 HK 13113705 A HK13113705 A HK 13113705A HK 1186378 A1 HK1186378 A1 HK 1186378A1
Authority
HK
Hong Kong
Prior art keywords
treatment
composition
anal rhagades
rhagades
anal
Prior art date
Application number
HK13113705.4A
Other languages
English (en)
Chinese (zh)
Inventor
Filippo Bastia
Maurizio Saccomanno
Original Assignee
Thd Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46001672&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1186378(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Thd Spa filed Critical Thd Spa
Publication of HK1186378A1 publication Critical patent/HK1186378A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK13113705.4A 2012-01-30 2013-12-10 A composition and use thereof in the treatment of anal rhagades HK1186378A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2012/000027 WO2013114410A1 (fr) 2012-01-30 2012-01-30 Composition et utilisation de celle-ci dans le traitement de rhagades anales

Publications (1)

Publication Number Publication Date
HK1186378A1 true HK1186378A1 (en) 2014-03-14

Family

ID=46001672

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13113705.4A HK1186378A1 (en) 2012-01-30 2013-12-10 A composition and use thereof in the treatment of anal rhagades

Country Status (24)

Country Link
US (1) US9345747B2 (fr)
EP (1) EP2646039B1 (fr)
JP (1) JP5903505B2 (fr)
KR (1) KR101599447B1 (fr)
CN (2) CN109865000A (fr)
AU (1) AU2012368815B2 (fr)
BR (1) BR112014018850A8 (fr)
CA (1) CA2863369C (fr)
DK (1) DK2646039T3 (fr)
ES (1) ES2485490T3 (fr)
HK (1) HK1186378A1 (fr)
HR (1) HRP20140594T1 (fr)
IL (1) IL233875A (fr)
IN (1) IN2014MN01733A (fr)
MX (1) MX336204B (fr)
PL (1) PL2646039T3 (fr)
RS (1) RS53457B (fr)
RU (1) RU2580622C2 (fr)
SA (1) SA113340239B1 (fr)
SG (1) SG11201404413UA (fr)
SI (1) SI2646039T1 (fr)
TW (1) TWI495476B (fr)
WO (1) WO2013114410A1 (fr)
ZA (1) ZA201405208B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2932156A1 (fr) 2013-12-24 2015-07-02 The Procter & Gamble Company Compositions cosmetiques et procedes permettant de procurer une penetration amelioree de principes actifs pour soin de la peau
ITRM20150163A1 (it) * 2015-04-17 2016-10-17 Uniderm Farm S R L Composizioni farmaceutiche per il trattamento delle ragadi anali
US10117826B2 (en) 2016-03-31 2018-11-06 Peter Angia Pham Bodily lubricating and moisturizing compositions containing plant mucilage
US10835504B2 (en) 2018-04-18 2020-11-17 G&S Laboratories, Inc. Compositions to treat anal itch
WO2020022991A2 (fr) * 2018-05-02 2020-01-30 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Compositions topiques contre les vergetures sur la peau
RU2771015C2 (ru) * 2020-09-25 2022-04-25 Общество с ограниченной ответственностью "ФАРМКОММ" Фармацевтическая композиция в виде мази для лечения геморроя

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
ATE214266T1 (de) * 1997-04-16 2002-03-15 Cognis France Sa Verwendung einer aus hibiskus-esculentus-samen extrahierten proteinfraktion in der kosmetik
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
CN1233469A (zh) * 1998-04-28 1999-11-03 王京杭 组织修复促进剂
JP2002204687A (ja) * 2000-11-09 2002-07-23 Onaka Yasushi β−１．３−１．６グルカン（アウレオバシジウム培養液）の医療、保健、福祉、食品および各種産業分野での応用
US6956120B2 (en) * 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
JP2003104832A (ja) * 2001-09-28 2003-04-09 Chifure Keshohin:Kk 皮膚外用剤
JP4544500B2 (ja) * 2002-07-19 2010-09-15 一丸ファルコス株式会社 ヒアルロン酸合成促進剤
EP1622627B1 (fr) * 2003-05-02 2013-05-22 Ceapro Inc. Compositions pharmaceutiques contenant un beta(1-3) beta(1-4) glucane de céréale
RU2277920C2 (ru) * 2004-02-24 2006-06-20 Государственное Учреждение "Пятигорский Государственный Научно-Исследовательский Институт Курортологии Министерства Здравоохранения Российской Федерации" Способ лечения детей, больных хроническим вирусным гепатитом, с применением сульфидных ванн и слабоуглекислой минеральной водой
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
JP5048935B2 (ja) * 2005-08-24 2012-10-17 株式会社ヤクルト本社 保湿剤
DE202007004856U1 (de) * 2007-04-01 2007-06-06 Rühle, Wilfried, Dipl.-Ing. CHM Anti Aging Komplex
CN101095482B (zh) * 2007-07-05 2012-02-15 中国科学院长春应用化学研究所 制备膳食纤维食品用大麦麦麸或燕麦麦麸的制法
US20090202664A1 (en) * 2008-02-11 2009-08-13 Svetislav Mikalacki Herbal cream or oil for the treatment hemorroids and wounds
ITUD20100112A1 (it) * 2010-06-09 2011-12-10 Farma Derma S R L Preparazione per uso vaginale e rettale e relativo procedimento di produzione
CN102084963A (zh) * 2010-09-29 2011-06-08 吉林省农业机械研究院 一种制备燕麦麦麸膳食纤维食品的方法

Also Published As

Publication number Publication date
RU2580622C2 (ru) 2016-04-10
SA113340239B1 (ar) 2015-07-07
HRP20140594T1 (hr) 2014-10-24
US20140303094A1 (en) 2014-10-09
TWI495476B (zh) 2015-08-11
CN109865000A (zh) 2019-06-11
JP2015504915A (ja) 2015-02-16
MX336204B (es) 2016-01-11
IN2014MN01733A (fr) 2015-07-10
SI2646039T1 (sl) 2014-10-30
CA2863369A1 (fr) 2013-08-08
CA2863369C (fr) 2020-03-10
KR101599447B1 (ko) 2016-03-14
AU2012368815A1 (en) 2014-09-18
SG11201404413UA (en) 2014-10-30
RS53457B (en) 2014-12-31
US9345747B2 (en) 2016-05-24
RU2014129391A (ru) 2016-03-27
TW201334787A (zh) 2013-09-01
AU2012368815B2 (en) 2018-03-01
IL233875A0 (en) 2014-09-30
ZA201405208B (en) 2015-10-28
DK2646039T3 (da) 2014-08-11
IL233875A (en) 2017-01-31
WO2013114410A1 (fr) 2013-08-08
BR112014018850A2 (fr) 2017-06-20
CN104114177A (zh) 2014-10-22
EP2646039A1 (fr) 2013-10-09
MX2014009244A (es) 2015-03-19
PL2646039T3 (pl) 2014-10-31
KR20140127296A (ko) 2014-11-03
ES2485490T3 (es) 2014-08-13
JP5903505B2 (ja) 2016-04-13
EP2646039B1 (fr) 2014-05-14
BR112014018850A8 (pt) 2017-07-11

Similar Documents

Publication Publication Date Title
HK1216176A1 (zh) 用於治療增殖性和自身免疫疾病的非對稱吡咯並苯並二氮雜卓二聚物
IL236616B (en) 5-aminotetrahydroquinoline-2-carboxylic acids and their use
IL234628A0 (en) Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs
HK1203493A1 (en) Substituted azabicycles and use thereof
EP2927281A4 (fr) Composition de résine et ses utilisations
EP2828258A4 (fr) Nouveaux dérivés de pyridopyrimidine et leur utilisation
GB201120993D0 (en) Novel compounds and their use in therapy
HK1214274A1 (zh) 用於治療肝臟疾病和心血管疾病的脂肽
EP2922536A4 (fr) Utilisation de bucillamine dans le traitement de la goutte
HK1217688A1 (zh) -氯- 苯基- -茚- -酮及其用途
HK1203198A1 (en) Substituted phenylimidazopyrazoles and use thereof
IL233875A0 (en) A preparation and its use for the treatment of anal fissures
EP2817304A4 (fr) Composés inédits et leur utilisation thérapeutique
GB201222455D0 (en) Novel pharmaceutical formulations and their use in the treatment of periodontaldisease
HK1209639A1 (en) Gpbp-1 inhibition and its therapeutic use gpbp-1
EP2744786A4 (fr) 2-imidazolidinones et 2-imidazolones substituées et leur utilisation dans le traitement du cancer
GB201308753D0 (en) Compounds and their use in therapy
ZA201503266B (en) Pyidone derivatives and uses thereof in the treatment of tuberculosis
ZA201405910B (en) Use of modafinil in the treatment of cocaine addicts
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
PL2895751T3 (pl) Śruba i jej zastosowanie
HK1207154A1 (en) C1q-adiponectin complex and use thereof c1q-
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
HUE048382T2 (hu) 6-klór-3-(fenil-d5)-inden-1-on és alkalmazása
GB201308217D0 (en) Compounds and their use in therapy

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180130